Abizer Gaslightwala - Jun 10, 2025 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
CEO, Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Stock symbol
AKTX
Transactions as of
Jun 10, 2025
Transactions value $
$25,400
Form type
4
Date filed
6/12/2025, 04:30 PM
Previous filing
Mar 24, 2025
Next filing
Jun 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gaslightwala Abizer CEO, Director C/O AKARI THERAPEUTICS PLC, 22 BOSTON WHARF ROAD FL 7, BOSTON /s/ Torsten Hombeck, as Attorney-in-Fact 2025-06-12 0002049375

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX American Depositary Shares representing Ordinary Shares Award $25.4K +20K +11.02% $1.27 201K Jun 10, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.
F2 On June 10, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.27 per ADS.